The University of Toledo

Faculty Research

Clinical Research
The Division of Gynecologic Oncology is actively involved in multiple local protocols along with national protocols through the Gynecologic Oncology Group. The Gynecologic Oncology Group is supported by The National Cancer Institute and provides major research involving gynecologic cancers. Local protocols include research on: aggressive surgery and chemotherapy for advanced ovarian cancer, surgical staging and brachytherapy without external radiation for endometrial cancer, other chemotherapy protocols, and studies on postoperative bowel stimulation to allow early postoperative discharge.

Basic Science Research
The clinical faculty in Gynecologic Oncology collaborate with the research faculty in the department of Biochemistry and Cancer Biology to study the etiology of ovarian cancer. Research is being performed on gap junction intercellular communications and telomerase activity in ovarian cancer and on the determination of pre-dysplastic genetic fingerprints in cervical dysplasia. 

Laboratory Research
Under the guidance of director, Rajesh Naz, Ph.D., this division continues to study the development of a contraceptive vaccine for men and women. This research project has been awarded a $1.2 million multi-year grant from the National Institutes of Health to support the ongoing endeavor.